Oncolytics Biotech Inc. appointed Matt Coffey as president and CEO, effective immediately.
Coffey was named the company's interim president and CEO in November 2016.
Oncolytics Biotech's interim CEO to head company on a permanent basis
COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021
Climate Credit Analytics: Linking climate scenarios to financial impacts
Global M&A Infographic Q1 2021
Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge
Oncolytics Biotech's interim CEO to head company on a permanent basis
- Author Muhammad Ahmer Gul Khan
- Theme Healthcare & Pharmaceuticals